Evidence map›Paper›PMID 38859730›Full record

ArticleJournal of extracellular vesicles2024

The Na

Irshad A Sheikh, Monica T Midura-Kiela, André Herchuelz, Sophie Sokolow, Pawel R Kiela, Fayez K Ghishan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of extracellular vesicles, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. The NaJournal of extracellular vesicles · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Irshad A SheikhDaniel Cracchiolo Institute for Pediatric Autoimmune Disease Research, Steele Children's Research Center, Department of Pediatrics, University of Arizona, Tucson, Arizona, USA.
Monica T Midura-KielaDaniel Cracchiolo Institute for Pediatric Autoimmune Disease Research, Steele Children's Research Center, Department of Pediatrics, University of Arizona, Tucson, Arizona, USA.
André HerchuelzLaboratoire de Pharmacodynamie et de Thérapeutique, Faculté de Médecine, Université Libre de Bruxelles, Bruxelles, Belgium.
Sophie SokolowSchool of Nursing, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Pawel R KielaDaniel Cracchiolo Institute for Pediatric Autoimmune Disease Research, Steele Children's Research Center, Department of Pediatrics, University of Arizona, Tucson, Arizona, USA.ORCID https://orcid.org/0000-0002-0014-3517
Fayez K GhishanDaniel Cracchiolo Institute for Pediatric Autoimmune Disease Research, Steele Children's Research Center, Department of Pediatrics, University of Arizona, Tucson, Arizona, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix vesicles (MVs) provide the initial site for amorphous hydroxyapatite (HA) formation within mineralizing osteoblasts. Although Na

Indexed as

Calcification, PhysiologicCalciumOsteoblastsSodium-Calcium ExchangerAnimalsCell DifferentiationCell LineExtracellular VesiclesFemaleMaleMiceMice, KnockoutOsteogenesisCalciumSlc8a3 protein, mouseSodium-Calcium Exchangermatrix vesiclesmineralizationNCX3osteoblasts

Identifiers

PMID38859730
PMCPMC11165172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.